115 related articles for article (PubMed ID: 8399148)
1. Inhibition of cytochrome P450 reductase by the diphenyliodonium cation. Kinetic analysis and covalent modifications.
Tew DG
Biochemistry; 1993 Sep; 32(38):10209-15. PubMed ID: 8399148
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of flavin reoxidation in P450 BM3 by diphenyliodonium chloride.
Munro AW; Coggins JR; Lindsay JG
Biochem Soc Trans; 1996 Feb; 24(1):17S. PubMed ID: 8674653
[No Abstract] [Full Text] [Related]
3. Stopped-flow kinetic studies of flavin reduction in human cytochrome P450 reductase and its component domains.
Gutierrez A; Lian LY; Wolf CR; Scrutton NS; Roberts GC
Biochemistry; 2001 Feb; 40(7):1964-75. PubMed ID: 11329263
[TBL] [Abstract][Full Text] [Related]
4. Involvement of phenyl radicals in iodonium inhibition of flavoenzymes.
O'Donnell VB; Smith GC; Jones OT
Mol Pharmacol; 1994 Oct; 46(4):778-85. PubMed ID: 7969060
[TBL] [Abstract][Full Text] [Related]
5. Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase.
O'Donnell BV; Tew DG; Jones OT; England PJ
Biochem J; 1993 Feb; 290 ( Pt 1)(Pt 1):41-9. PubMed ID: 8439298
[TBL] [Abstract][Full Text] [Related]
6. Purification of flavin mononucleotide-dependent and flavin-adenine dinucleotide-dependent reduced nicotinamide-adenine dinucleotide phosphate-cytochrome P-450 reductase by high-performance liquid chromatography on hydroxyapatite.
Kurzban GP; Strobel HW
J Chromatogr; 1986 May; 358(1):296-301. PubMed ID: 3088018
[No Abstract] [Full Text] [Related]
7. Functional interactions in cytochrome P450BM3. Evidence that NADP(H) binding controls redox potentials of the flavin cofactors.
Murataliev MB; Feyereisen R
Biochemistry; 2000 Oct; 39(41):12699-707. PubMed ID: 11027150
[TBL] [Abstract][Full Text] [Related]
8. Electron transfer by human wild-type and A287P mutant P450 oxidoreductase assessed by transient kinetics: functional basis of P450 oxidoreductase deficiency.
Jin Y; Chen M; Penning TM; Miller WL
Biochem J; 2015 May; 468(1):25-31. PubMed ID: 25728647
[TBL] [Abstract][Full Text] [Related]
9. Dissection of NADPH-cytochrome P450 oxidoreductase into distinct functional domains.
Smith GC; Tew DG; Wolf CR
Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8710-4. PubMed ID: 8078947
[TBL] [Abstract][Full Text] [Related]
10. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
Roitel O; Scrutton NS; Munro AW
Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
[TBL] [Abstract][Full Text] [Related]
11. NADPH-cytochrome P-450 oxidoreductase: flavin mononucleotide and flavin adenine dinucleotide domains evolved from different flavoproteins.
Porter TD; Kasper CB
Biochemistry; 1986 Apr; 25(7):1682-7. PubMed ID: 3085707
[TBL] [Abstract][Full Text] [Related]
12. Obligatory intermolecular electron-transfer from FAD to FMN in dimeric P450BM-3.
Kitazume T; Haines DC; Estabrook RW; Chen B; Peterson JA
Biochemistry; 2007 Oct; 46(42):11892-901. PubMed ID: 17902705
[TBL] [Abstract][Full Text] [Related]
13. Structural studies on FMN domain of cytochrome P450 reductase.
Modi S; Lian LY; Roberts GC; Smith GC; Paine M; Wolf CR
Biochem Soc Trans; 1995 Aug; 23(3):476S. PubMed ID: 8566373
[No Abstract] [Full Text] [Related]
14. Interflavin one-electron transfer in the inducible nitric oxide synthase reductase domain and NADPH-cytochrome P450 reductase.
Yamamoto K; Kimura S; Shiro Y; Iyanagi T
Arch Biochem Biophys; 2005 Aug; 440(1):65-78. PubMed ID: 16009330
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of FAD-dependent cytochrome P450 reductase activity by photoreduction.
Hodgson AV; Strobel HW
Anal Biochem; 1996 Dec; 243(1):154-7. PubMed ID: 8954538
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the FAD-binding domain of the sulphite reductase flavoprotein component from Escherichia coli and its inhibition by iodonium diphenyl chloride.
Covès J; Lebrun C; Gervasi G; Dalbon P; Fontecave M
Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):465-72. PubMed ID: 10455035
[TBL] [Abstract][Full Text] [Related]
17. The closed and compact domain organization of the 70-kDa human cytochrome P450 reductase in its oxidized state as revealed by NMR.
Vincent B; Morellet N; Fatemi F; Aigrain L; Truan G; Guittet E; Lescop E
J Mol Biol; 2012 Jul; 420(4-5):296-309. PubMed ID: 22543241
[TBL] [Abstract][Full Text] [Related]
18. Differential transfers of reduced flavin cofactor and product by bacterial flavin reductase to luciferase.
Jeffers CE; Tu SC
Biochemistry; 2001 Feb; 40(6):1749-54. PubMed ID: 11327836
[TBL] [Abstract][Full Text] [Related]
19. Trp-676 facilitates nicotinamide coenzyme exchange in the reductive half-reaction of human cytochrome P450 reductase: properties of the soluble W676H and W676A mutant reductases.
Gutierrez A; Doehr O; Paine M; Wolf CR; Scrutton NS; Roberts GC
Biochemistry; 2000 Dec; 39(51):15990-9. PubMed ID: 11123926
[TBL] [Abstract][Full Text] [Related]
20. Flavin-binding and protein structural integrity studies on NADPH-cytochrome P450 reductase are consistent with the presence of distinct domains.
Narayanasami R; Horowitz PM; Masters BS
Arch Biochem Biophys; 1995 Jan; 316(1):267-74. PubMed ID: 7840627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
